In Chronic hepatitis B virus (HBV) infection Imualfa 1.6mg Injection works by preventing the HBV virus from multiplying in the body. It helps control the infection and makes the immune system work better. This lowers the chances of getting complications and improves the quality of life. This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HBV infection. Imualfa 1.6mg Injection is given by a doctor or a nurse and should not be self-administered. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
It is not known whether it is safe to consume alcohol with Imualfa 1.6mg Injection. Please consult your doctor.
Imualfa 1.6mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Imualfa 1.6mg Injection during breastfeeding is not available. Please consult your doctor.
It is not known whether Imualfa 1.6mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Imualfa 1.6mg Injection in patients with kidney disease. Please consult your doctor.
Imualfa 1.6mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Imualfa 1.6mg Injection may not be needed in these patients. Please consult your doctor.
If you miss a dose of Imualfa 1.6mg Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)